Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
08/2006
08/23/2006EP1693365A1 Inhibitors of dipeptidyl peptidase IV
08/23/2006EP1692114A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
08/23/2006EP1363920B1 Modified psma ligands and uses related thereto
08/23/2006EP1345907B1 7-heterocyclyl quinoline and thieno 2,3-b|pyridine derivatives useful as antagonists of gonadotropin releasing hormone
08/23/2006EP1332144B1 Indole derivatives as pde5-inhibitors
08/23/2006EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
08/23/2006EP1237537B1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof
08/23/2006CN1823039A Cyclic aminophenyl sulfamate derivative
08/23/2006CN1822848A Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions
08/23/2006CN1821379A Method for preparing micrometer ginseng, pilose antler, pearl and pollen pini yang strengthening wine
08/23/2006CN1820780A Method for preparing Fuyankang extract
08/23/2006CN1820766A Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen oral liquor for strengthening yang, removing fatigue and supplementing calcium
08/23/2006CN1820765A Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen calcium supplement granule capsule and tablet for strengthening yang, removing fatigue and supplementing calcium
08/23/2006CN1820736A Use of 1,4-naphthalene diphenol in preparing external use sperm killing contraceptive medicine of preventing and curing genital tract infection
08/23/2006CN1270751C Chinese traditional medicine preparation for treating male infertility and preparation method thereof
08/23/2006CN1270740C Ready prepared Chinese medicine for treating angeitis and preparation process
08/23/2006CN1270736C Chinese traditional medicine composition for impotence, its preparation method and quality control method
08/23/2006CN1270726C Method of producing disinfecting and sterilizing fomulation for vaginal mucosa
08/23/2006CN1270719C Pharmaceutical composition for treatment of phimosis using topical corticosteroid
08/23/2006CN1270718C Epiallopregnanolone in the treatment of CNS disorders
08/23/2006CN1270715C Medicinal preparation of general alkaloid of bocconia cordata and producing method
08/22/2006US7094896 Diaminothiazoles having antiproliferative activity
08/22/2006US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate
08/22/2006US7094781 Sulfamides and their use as endothelin receptor antagonists
08/22/2006US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction
08/22/2006US7094547 Sperm specific proteins
08/22/2006US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating
08/17/2006WO2006085497A1 Tablet disintegrating in the oral cavity
08/17/2006WO2006085330A2 Use of protein tyrosine kinase inhibitors for the treatment of leiomyomas
08/17/2006WO2006084937A1 Method for diagnosing and treating women with increased response to hormonal replacement therapy
08/17/2006WO2006046135A3 Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors
08/17/2006US20060183931 Multi-substituted selective androgen receptor modulators and methods of use thereof
08/17/2006US20060183774 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
08/17/2006US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
08/17/2006US20060183736 Selective estrogen receptor modulators containing a phenylsulfonyl group
08/17/2006US20060183105 Human brain-derived tissue-specific potassium channel
08/17/2006DE10159120B4 Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung Steroid hormone-containing transdermal therapeutic systems containing Propylenglycolmonocaprylat and its use
08/16/2006EP1690543A1 Pharmaceutical composition for contraception
08/16/2006EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor
08/16/2006EP1689447A2 Gene transfer for regulating smooth muscle tone
08/16/2006EP1689423A2 Regulation of sperm function
08/16/2006EP1689416A1 Disinfecting composition and methods of making and using same
08/16/2006EP1689413A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids
08/16/2006EP1689411A2 Graduated estrogen contraceptive
08/16/2006EP1689409A1 Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions
08/16/2006EP1482948B1 Continuous sulfatase inhibiting progestogen hormone replacement therapy
08/16/2006EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
08/16/2006EP1337247B1 Use of Gaboxadol for the treatment of premenstrual disorder, postnatal depression or postmenopausal related dysphoric disorder
08/16/2006EP1183020B1 (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes
08/16/2006EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
08/16/2006EP1094799B1 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
08/16/2006EP1019075B9 Beta 2-adrenergic receptor agonists
08/16/2006CN1817882A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/16/2006CN1817854A Amino acids with affinity for the alpha-2-delta protein
08/16/2006CN1817359A Chinese medicinal preparation for treating gynecopathy and production thereof
08/16/2006CN1269942C Hops extracts, method for prodn. and use
08/16/2006CN1269804C Metalloproteinase inhibitors
08/16/2006CN1269497C Medicated bra for treating mastoproliferation
08/16/2006CN1269479C Externally used liquid preparation containing fibrauretine and its application on genital tract, oral cavity and upper respiratory tract
08/15/2006US7091234 Thio-oxindole derivatives
08/15/2006US7091227 Serine/threonine and tyrosine kinases inhibitors
08/15/2006US7091224 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors
08/15/2006US7091215 Corticotropin-Releasing Factor (CRF) receptor antagonist
08/15/2006US7091204 Sulfonamides
08/15/2006US7091203 Imidazo[1,3,5]triazinones and their use
08/15/2006US7091195 Derived from plants; for preventing or inhibiting tumor growth
08/15/2006US7090871 Composition containing pyrrolizidine-alkaloid-free petasites
08/15/2006CA2395231C Hydrogel-driven layered drug dosage form
08/15/2006CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity
08/10/2006WO2006084082A1 Compositions of unconjugated estrogens and methods for their use
08/10/2006WO2006083005A1 Fused pyrimidine derivative and used thereof
08/10/2006WO2006082952A1 Amide compound
08/10/2006WO2006082596A2 Neem oil contraceptive formulations
08/10/2006WO2006082511A1 Novel salt form of a dopamine agonist
08/10/2006WO2006081743A1 Medicament for treating cervical erosion and method for its preparation
08/10/2006WO2005041856A3 Use of 2-thia-dibenzo[e, h]azulenes for the treatment and prevention of central nervous system diseases and disorders
08/10/2006US20060178420 Indole derivatives as anti-inflammatory agents
08/10/2006US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease
08/10/2006US20060178409 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors
08/10/2006US20060178394 Inhalable dose of a powder comprising apomorphine or pharmaceutically acceptable salts thereof for therapy of for sexual dysfunction
08/10/2006US20060178372 Therapeutic quinoline compounds
08/10/2006US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides
08/10/2006US20060178362 Substituted heterocyle fused gamma-carbolines
08/10/2006US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents
08/10/2006US20060178337 Method for diagnosing aplasia of corpus callosum
08/10/2006US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
08/10/2006US20060177432 Methods and reagents for protease inhibition
08/10/2006US20060177382 Delivery of antiemetics through an inhalation route
08/10/2006CA2601773A1 Compositions of unconjugated estrogens and methods for their use
08/10/2006CA2590549A1 Therapeutic agent for polycystic ovary syndrome (pcos)
08/09/2006EP1688434A1 Antibody and use of the same
08/09/2006EP1688149A1 Paste formulations comprising silica
08/09/2006EP1687440A1 Improvements relating to semen preservation
08/09/2006EP1453832B1 Ring fused pyrazole derivatives
08/09/2006EP1397361B1 Carboline derivatives as pdev inhibitors
08/09/2006EP1317453B1 Isoxazoles and their use as inhibitors of erk
08/09/2006EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
08/09/2006EP1144003B1 Methods and devices for delivery of agents to breast milk ducts
08/09/2006EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands
08/09/2006CN1814256A Use of compound Rhizoma-curcumae-zedoariae oil suppository preparing medicine for treating desquamating colpitis